Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 5—May 2026

Dispatch

Severe Respiratory Illness and Death Associated with Outbreak of Human Rhinovirus B14 among Older Adults, France, 2024

Julien Andreani, Céline Boschi, Anne Decoppet, Jeremy Delerce, Gwilherm Penant, Aylin Karadeniz, Clio Grimaldier, Priscilla Jardot, Laure Zangoli, Maud Mandy, Nicole Vigroux, Florent Polesso, Sophie Edouard, Philippe Cano, Jean-Christophe Lagier, Bernard La ScolaComments to Author , and Philippe ColsonComments to Author 
Author affiliation: Institut hospitalo-universitaire Méditerranée Infection, Marseille, France (J. Andreani, C. Boschi, J. Delerce, G. Penant, A. Karadeniz, C. Grimaldier, P. Jardot, S. Edouard, J.-C. Lagier, B. La Scola, P. Colson); Aix-Marseille University, Marseille (J. Andreani, C. Boschi, J. Delerce, S. Edouard, J.-C. Lagier, B. La Scola, P. Colson); Assistance Publique-Hôpitaux de Marseille, Marseille (J. Andreani, C. Boschi, G. Penant, A. Karadeniz, C. Grimaldier, P. Jardot, J.-C. Lagier, B. La Scola, P. Colson); Agence Régionale de la Santé Provence-Alpes Côte d’Azur, Marseille (A. Decoppet, P. Cano); Centre Hospitalier Intercommunal de Brignoles–Le Luc, Brignoles, France (L. Zangoli, M. Mandy, F. Polesso); Laboratoire de Biologie Médicale Eurofins, Garéoult, France (N. Vigroux)

Main Article

Figure 1

Timeline of severe respiratory illness and death associated with outbreak of HRV-B14 among older adults, France, 2024. Each row represents 1 case and starts on the day of symptom onset, on the basis of retrospectively collected information. Crosses indicate timeline for death. Purple squares indicate HRV RNA–positive samples. The green vertical dotted line indicates transfer of clinical samples to the Marseille laboratory for more extensive diagnosis and metagenomic analyses. Patient 9 had 2 additional HRV-positive postmortem samples (data not shown). No tests were performed for cases P15–P18. No nasopharyngeal swab sample was available for P2. HRV, human rhinovirus.

Figure 1. Timeline of severe respiratory illness and death associated with outbreak of HRV-B14 among older adults, France, 2024. Each row represents 1 case and starts on the day of symptom onset, on the basis of retrospectively collected information. Crosses indicate timeline for death. Purple squares indicate HRV RNA–positive samples. The green vertical dotted line indicates transfer of clinical samples to the Marseille laboratory for more extensive diagnosis and metagenomic analyses. Patient 9 had 2 additional HRV-positive postmortem samples (data not shown). No tests were performed for cases P15–P18. No nasopharyngeal swab sample was available for P2. HRV, human rhinovirus.

Main Article

Page created: March 19, 2026
Page updated: May 01, 2026
Page reviewed: May 01, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external